The Johns Hopkins Bloomberg School of Public Health has established a new research center dedicated to improving the safety and effectiveness of medications. Led by Bloomberg School faculty in collaboration with colleagues from the Johns Hopkins School of Medicine and the Zanvyl Kreiger School of Arts and Sciences, the Center for Drug Safety and Effectiveness will address prescription drug use and pharmaceutical policy in the United States and abroad. Core faculty will focus on research, training, clinical care and public service.
24 October, 2012
Dotmatics Limited, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announced that The Institute of Cancer Research, London, has licensed and deployed the Dotmatics informatics platform.
18 October, 2012
Last week British scientist Sir John Gurdon and Shinya Yamanaka were awarded the Nobel Prize in Physiology or Medicine 2012 for their ground breaking work in stem cell research.
15 October, 2012
BerGenBio, an emerging oncology biopharma announced the signing of a contract with Sygnature Discovery, Nottingham, UK, for the pre-clinical development of a small molecule inhibitor against a novel target that mediates highly aggressive drug-resistant tumours.
11 October, 2012